Pharmaceutical Technology

MAY 19, 2023

Multiple sclerosis (MS) is a primary autoimmune disease in which inflammation is a core contributor to the degeneration of the central nervous system (CNS), leading to neurological disability and affecting sensory, visual, motor, and autonomic systems. DMTs for MS have a high price tag, particularly in the US.

Marketing 246

Marketing Development Drugs 246

Pharmaceutical Technology

DECEMBER 5, 2022

Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. This is closely followed by CB2 receptors in second place.

Regulation 245

Regulation Drugs Development Marketing 245

The Pharma Data

JANUARY 31, 2021

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins. —- End —-.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

XTalks

OCTOBER 12, 2022

Currently, MRI-based perfusion imaging is also being applied to measure changes in inflammation in patients with rheumatoid arthritis and osteoarthritis. Vascular Perfusion Imaging May be Used to Measure Markers of Inflammation. Various perfusion-related parameters can be measured using dynamic contrast-enhanced MRI (DCE-MRI).

Clinical Trials 93

Clinical Trials Clinical Trials Trials Drugs 93

The Pharma Data

DECEMBER 3, 2020

Utilizing Clover’s proprietary Trimer-Tag © technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag © Technology. Trimer-Tag © is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

JANUARY 31, 2021

Utilizing Clover’s proprietary Trimer-Tag© technology, S-Trimer is a trimeric SARS-CoV-2 spike (S)-protein subunit vaccine candidate. About Trimer-Tag© Technology. Trimer-Tag© is an innovative drug development platform which allows the production of novel, covalently-trimerized fusion proteins.

Vaccination 52

Vaccination Vaccine Trials Protein 52

The Pharma Data

MAY 4, 2021

Inflammation & Immunology. 1,611. . *. *. Internal Medicine. Rare Disease. Total Revenue. 42%. . . . . . Indicates calculation not meaningful. The information contained on our website or any third-party website is not incorporated by reference into this earnings release. View source version on businesswire.com : [link].

Vaccination 40

Vaccination Vaccine Production Sales 40